Literature DB >> 2648255

DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines.

D Darling1, M Tavassoli, M H Linskens, F Farzaneh.   

Abstract

The nuclear proto-oncogene c-myc is believed to play a regulatory role in eukaryotic cellular growth and differentiation. Several studies have demonstrated rapid down-regulation of the steady-state levels of c-myc RNA during DMSO induced differentiation of the human 'promyelocytic' cell line, HL-60. However, little is known about the effect of DMSO on c-myc regulation in cells which are not induced to differentiate by DMSO. We have examined the effect of DMSO on c-myc RNA levels in a number of cell lines with different lesions in the c-myc gene, including those which do not differentiate in response to DMSO treatment. Here we demonstrate that DMSO induces a rapid, but transient, reduction in the steady-state level of c-myc RNA in human 'erythroid' K562 cells, Burkitt lymphoma lines Daudi and Raji, human T cell lymphoblastoid line CEM and mouse lymphoma line L1210. However, DMSO treatment does not produce a similar effect in the human colon adenocarcinoma cell line COLO 320 or HeLa epithelial cervical carcinoma cells. These observations demonstrate that the DMSO induced modulation of c-myc RNA levels is a more common phenomenon than previously recognised, and is not necessarily correlated with either the induction of cellular differentiation or growth arrest.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2648255

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells.

Authors:  G D Spotts; S R Hann
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

2.  Influence of dimethyl sulphoxide on intermediate filament proteins in human rhabdomyosarcoma cell lines: modulation at subcellular level.

Authors:  C Melguizo; J Prados; C Velez; A E Aranega; L Alvarez; A Aranega
Journal:  Histochem J       Date:  1994-06

3.  Structure and regulation of the mDot1 gene, a mouse histone H3 methyltransferase.

Authors:  Wenzheng Zhang; Yoshihide Hayashizaki; Bruce C Kone
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

4.  Ca2+ signalling in K562 human erythroleukaemia cells: effect of dimethyl sulphoxide and role of G-proteins in thrombin- and thromboxane A2-activated pathways.

Authors:  C P Thomas; M J Dunn; R Mattera
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

5.  c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.

Authors:  M Tavassoli; P Quirke; F Farzaneh; N J Lock; L V Mayne; N Kirkham
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

6.  Relationship of myc protein expression to the phenotype and to the growth potential of HOC-7 ovarian cancer cells.

Authors:  C Somay; T W Grunt; C Mannhalter; C Dittrich
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

7.  Comparison of Different Electroporation Parameters on Transfection Efficiency of Sheep Testicular Cells.

Authors:  Sarah Niakan; Banafsheh Heidari; Ghasem Akbari; Zahra Nikousefat
Journal:  Cell J       Date:  2016-08-24       Impact factor: 2.479

8.  Transcriptional and Epigenetic Consequences of DMSO Treatment on HepaRG Cells.

Authors:  Hélène Dubois-Pot-Schneider; Caroline Aninat; Kathrin Kattler; Karim Fekir; Kathleen Jarnouen; Virginie Cerec; Denise Glaise; Abdulrahman Salhab; Gilles Gasparoni; Kubo Takashi; Seiichi Ishida; Jörn Walter; Anne Corlu
Journal:  Cells       Date:  2022-07-26       Impact factor: 7.666

9.  c-Myc interferes with the commitment to differentiation of murine erythroleukemia cells at a reversible point.

Authors:  S Takada; T Yamamoto; Y Ohmori; Y Matsui; M Obinata
Journal:  Jpn J Cancer Res       Date:  1992-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.